Prognostic impact of pretreatment immunoglobulin clonal composition in pediatric B-lymphoblastic leukemia
Haematologica
.
2023 Mar 1;108(3):900-904.
doi: 10.3324/haematol.2022.281146.
Authors
Carol Fries
1
,
Lik Wee Lee
2
,
Meenakshi Devidas
3
,
Yunfeng Dai
4
,
Karen R Rabin
5
,
Sumit Gupta
6
,
Mignon L Loh
7
,
Ilan R Kirsch
2
,
Brent Wood
8
,
Rachel E Rau
5
Affiliations
1
Department of Pediatrics, Hematology/Oncology, University of Rochester, Rochester.
[email protected]
.
2
Adaptive Biotechnologies, Inc., Seattle, WA.
3
Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis.
4
Department of Biostatistics, College of Medicine and Public Health and Health Professions, University of Florida, Gainesville, FL.
5
Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston.
6
Division of Hematology/Oncology, Hospital for Sick Children, Faculty of Medicine, University of Toronto, Toronto, ON.
7
Department of Pediatrics, Ben Towne Center for Childhood Cancer Research, Seattle Children's Hospital, Seattle, WA.
8
Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA.
PMID:
36325891
PMCID:
PMC9973485
DOI:
10.3324/haematol.2022.281146
No abstract available
Publication types
Research Support, N.I.H., Extramural
Letter
MeSH terms
Child
Genes, Immunoglobulin
Humans
Immunoglobulins*
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics
Prognosis
Substances
Immunoglobulins
Grants and funding
U10 CA180886/CA/NCI NIH HHS/United States
U10 CA180899/CA/NCI NIH HHS/United States
UG1 CA233249/CA/NCI NIH HHS/United States